Found 10 matching trials
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. NA The goal of this prospective clinical study is to evaluate the safety and e...
Show More Location
The Catholic University of Korea Seoul St.Mary's Hospital
Learn More & Join Trial
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation PHASE1 The purpose of this study is to evaluate whether virus-specific T cell line...
Show More Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Learn More & Join Trial
Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV PHASE1 The primary purpose of this phase I/II study is to evaluate whether partial...
Show More Location
UPMC (University of Pittsburgh Medical Center)
Learn More & Join Trial
Third Party Viral Specific T-cells (VSTs) PHASE2 The purpose of this study is to demonstrate that viral specific T-cells (a ...
Show More Location
Akron Children's Hospital
Learn More & Join Trial
Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT PHASE1 The aim of the study is to evaluate the adverse events and the efficacy of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Donor-Derived Viral Specific T-cells (VSTs) PHASE1 In this research study, the investigators want to learn more about the use ...
Show More Location
Akron Children's Hospital
Learn More & Join Trial
Allogeneic Virus-specific T Cell Lines (VSTs) PHASE1 The primary purpose of the study is to evaluate whether most closely HLA-ma...
Show More Location
Childrens National Medical Center
Learn More & Join Trial
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. PHASE1 The purpose of this study is to use VSTs (virus-specific T cells) from a do...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
TETRAVI Expanded Access Program N/A This Expanded Access Program (EAP) allows qualified physicians within Texas...
Show More Location
Multiple Locations
Learn More & Join Trial
CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency NA Treatment of CMV in a patient with profound combined immunodeficiency, who ...
Show More Status
Active Not Recruiting
Location
Alberta Children's Hospital
Learn More & Join Trial